Integra Lifesciences Holdings Corp (IART)
29.38
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
29.36
-0.02
(-0.07%)
After-Hours: 20:00
Integra Lifesciences Holdings Free Cash Flow: 73.09M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.09M |
| September 30, 2023 | 109.75M |
| June 30, 2023 | 155.22M |
| March 31, 2023 | 199.56M |
| December 31, 2022 | 217.38M |
| September 30, 2022 | 188.30M |
| June 30, 2022 | 204.63M |
| March 31, 2022 | 232.22M |
| December 31, 2021 | 264.35M |
| September 30, 2021 | 274.39M |
| June 30, 2021 | 261.81M |
| March 31, 2021 | 203.05M |
| December 31, 2020 | 139.94M |
| September 30, 2020 | 155.10M |
| June 30, 2020 | 77.84M |
| March 31, 2020 | 82.80M |
| December 31, 2019 | 96.90M |
| September 30, 2019 | 46.91M |
| June 30, 2019 | 123.84M |
| March 31, 2019 | 109.20M |
| December 31, 2018 | 121.94M |
| September 30, 2018 | 102.79M |
| June 30, 2018 | 77.66M |
| March 31, 2018 | 77.49M |
| December 31, 2017 | 71.04M |
| Date | Value |
|---|---|
| September 30, 2017 | 58.53M |
| June 30, 2017 | 60.87M |
| March 31, 2017 | 74.63M |
| December 31, 2016 | 69.08M |
| September 30, 2016 | 96.28M |
| June 30, 2016 | 70.74M |
| March 31, 2016 | 59.29M |
| December 31, 2015 | 71.44M |
| September 30, 2015 | 72.05M |
| June 30, 2015 | 82.46M |
| March 31, 2015 | 71.12M |
| December 31, 2014 | 44.75M |
| September 30, 2014 | 38.72M |
| June 30, 2014 | 31.62M |
| March 31, 2014 | 13.89M |
| December 31, 2013 | 10.97M |
| September 30, 2013 | -24.22M |
| June 30, 2013 | -33.59M |
| March 31, 2013 | -34.84M |
| December 31, 2012 | -9.931M |
| September 30, 2012 | 39.80M |
| June 30, 2012 | 43.16M |
| March 31, 2012 | 72.48M |
| December 31, 2011 | 65.90M |
| September 30, 2011 | 54.44M |
Free Cash Flow Range, Past 5 Years
46.91M
Minimum
Sep 2019
274.39M
Maximum
Sep 2021
163.53M
Average
155.22M
Median
Jun 2023
Free Cash Flow Benchmarks
| Stryker Corp | 3.136B |
| OraSure Technologies Inc | 131.28M |
| Insulet Corp | 36.50M |
| PROCEPT BioRobotics Corp | -133.21M |
| Perspective Therapeutics Inc | -37.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 58.75M |
| Cash from Investing (Quarterly) | -57.23M |
| Cash from Financing (Quarterly) | -6.89M |
| Free Cash Flow Per Share (Quarterly) | 0.4386 |
| Free Cash Flow to Equity (Quarterly) | 39.67M |
| Free Cash Flow to Firm (Quarterly) | 40.54M |
| Free Cash Flow Yield | 3.10% |